GEN Exclusives

More »

GEN News Highlights

More »
Mar 30, 2007

Cells Involved in Liver Damage Play Dual Role as Tissue Repair Agent

  • Researchers found that immediately following liver injury, a cellular receptor, p75 neurotrophin receptor (p75NTR), involved in triggering cell death is also a necessary component of tissue repair and regeneration. They describe the mechanism by which cells associated with liver damage, or hepatic stellate cells (HSCs), are activated by p75NTR to promote repair in the liver.

    The investigators looked at the molecular-cellular interface to study how tissues responded to deposition of fibrin. In studies of mice with excessive fibrin deposition in the liver, they found that p75NTR signaling promotes the initial activation of HSC, which stimulates the proliferation of new hepatic cells to replace those that have been damaged. The effects of p75NTR at late stages of HSC activation and liver disease remain to be determined.

    "Many therapeutics for liver disease target HSCs in order to kill them, but our study found that their initial activity could actually be protective," points out Katerina Akassoglou, Ph.D., assistant professor at the the University of California, San Diego, department of pharmacology, where the research was undertaken.

    "By identifying p75NTR as the specific molecular link between HSCs and liver regeneration, p75NTR could provide a new therapeutic target for promoting cell regeneration and repair during chronic liver disease or injury."

    The study was published in the March 30 issue of Science.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »